Skip to content
Living

Seed Money for Healthcare Startups in Southeast Asia

By Aiko TanakaSingapore
1 min read
healthcare
healthcare
In this article (5)

HealthXCapital launched Emerging Asia’s first healthcare-focused early stage VC fund, according to a media release sent on Thursday.

Backed by Apollo Hospitals, Jungle Ventures, Eight Roads Ventures (the proprietary investment arm of Fidelity International), and other private investors, early stage venture firm HealthXCapital aims to fuel healthcare innovation in Asia’s emerging economies.

Healthcare Has Not Kept Pace

The region has experienced one of the world’s fastest growths stories but healthcare has not kept pace. We believe that HealthXCapital can foster healthcare innovation in Asia in order to improve patient outcomes, access and affordability in our core demographies, said Suneeta Reddy, Managing Director of the Apollo Hospitals Group.

HealthXCapital has launched a $25 million fund to provide smart, connected capital to healthcare startups focused on emerging markets in South Asia and Southeast Asia.

Perennial Challenges

The firm invests and works intensively with healthcare startups to augment their commercialisation and bring accessible socio-economic benefits to Asia’s healthcare ecosystem.

Asia faces perennial challenges such as underdeveloped infrastructure, affordability of treatments, lack of proactive healthcare and opaque data management. While healthcare expenditure is growing fast, it still continues to lag. Large gaps remain in the Asian healthcare systems, Reddy added.

Ripe For Disruption

These gaps are also driving strong demand for technology in the $517 billion opportunity in 2018 as projected in a recent report published by Frost & Sullivan.

Our aim at HealthXCapital is to help modernise a sector which has long been ripe for disruption. We want to grow the best domestic and global healthcare technologies by helping them rapidly scale across emerging Asian markets, said Seemant Jauhari, Partner at HealthXCapital.

Questions & Answers

Q.

Which specific regions will HealthXCapital's new fund primarily focus on for its investments?

A.

The $25 million fund is designed to provide capital to healthcare startups that are focused on emerging markets within both South Asia and Southeast Asia. This highlights their geographical scope for innovation.

Q.

What are the main problems HealthXCapital aims to address within the Asian healthcare sector?

A.

HealthXCapital seeks to tackle perennial challenges such as underdeveloped infrastructure, issues with treatment affordability, a lack of proactive healthcare, and opaque data management systems across Asia. These are key areas for improvement.

Q.

Which prominent organisations are backing HealthXCapital's new early-stage venture fund?

A.

The fund is supported by several notable backers including Apollo Hospitals, Jungle Ventures, and Eight Roads Ventures, which is the proprietary investment arm of Fidelity International. Other private investors are also involved.

Q.

What is the projected market opportunity for technology in the healthcare sector that HealthXCapital is targeting?

A.

A recent Frost & Sullivan report projected a significant market opportunity of $517 billion in 2018 for technology within the healthcare sector. This large figure indicates the potential for disruption and growth.

Reader pulse

Is this a smart investment?

18,213 votes so far

Weekly Briefing

Asia's retail intelligence, in your inbox

Tuesday, Thursday and a Saturday Weekly Wrap: the retail stories, numbers and moves that mattered across Asia. Nothing else, and you can unsubscribe in one click.

  • Top industry moves and market shifts
  • Weekly data-driven analysis from across Asia
  • Tuesday, Thursday and the Saturday Weekly Wrap

Read by retail operators, investors and brand teams across Asia.

Protected by a quick human check. No spam, ever. Unsubscribe in one click.

SecureGDPR ready